New telemedicine model aims to keep vulnerable heart patients out of hospital

NCT ID NCT06176131

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a telemedicine-based care model for heart failure patients who are frequently readmitted to hospital and cannot join standard rehab. Researchers will provide on-demand video and chat support from cardiologists to general practitioners and community health workers. The goal is to see if this approach reduces hospital readmissions and improves quality of life. About 300 patients will take part.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Telemedicine-based cross-sector collaboration model
What this could lead to
If successful, this could show a practical way to reduce hospital readmissions and improve quality of life for heart failure patients who cannot attend standard rehab.
What could go wrong
This is an observational study, not a controlled trial, so results may be influenced by other factors. It is also limited to a specific patient group and healthcare setting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cardiology department Y, Bispebjerg-Frederiksberg Hospital

    RECRUITING

    Frederiksberg, 2000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.